Market Research Logo

Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), Application (Drug Discovery & Development, Preclinical, Clinical Trial) & by End Users - Global Forecast to 2020

Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), Application (Drug Discovery & Development, Preclinical, Clinical Trial) & by End Users - Global Forecast to 2020

The global biosimulation market is expected to reach USD 2,107.99 million by 2020 from USD 1,034.93 million in 2015, at a CAGR of 15.29% between 2015 and 2020. By product, the market includes software and services. Based on application, the market is segmented into drug discovery, drug development, and others (defense, industrial bioprocessing, nutraceuticals, and agri-food production). The drug development application segment is further classified into preclinical testing and clinical trials. Preclinical testing includes ADME/Tox and PK/PD applications. The drug discovery segment is divided into target identification & validation and lead identification & optimization. The drug development segment will hold the largest share of the biosimulation market in 2015. The other applications segment is expected to grow at the highest rate.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share in the global biosimulation market in 2015. Europe is expected to register the fastest growth.

Market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. Other growth factors include the need to curtail drug discovery & development costs, technological advancements, growth in the biologics and biosimilars markets, and the increased use of personalized medicines.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global biosimulation market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
Product Development: Product portfolios of the top players in the biosimulation market.
Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the biosimulation market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biosimulation products and services across geographies.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • Table BIOSIMULATION MARKET SUMMARY
  • PREMIUM INSIGHTS
    • LUCRATIVE OPPORTUNITIES IN THE GLOBAL BIOSIMULATION MARKET
    • LIFE CYCLE ANALYSIS, BY REGION (2015-2020)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • BY PRODUCT
      • BY APPLICATION
      • BY END USER
    • MARKET DYNAMICS
      • DRIVERS
        • Table GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES ALONG WITH INCREASE IN R&D INVESTMENTS IN THESE INDUSTRIES IS PROPELLING THE GROWTH OF THE BIOSIMULATION MARKET
      • RESTRAINTS
        • Table LACK OF STANDARDIZATION TO RESTRICT MARKET GROWTH
      • OPPORTUNITIES
        • Table EMERGING APPLICATIONS PRESENT SIGNIFICANT GROWTH OPPORTUNITIES FOR THE BIOSIMULATION MARKET
      • CHALLENGES
        • Table LIMITED KNOWLEDGE OF BIOLOGICAL SYSTEMS AND PROCESSES POSE A CHALLENGE FOR THE BIOSIMULATION MARKET
      • TRENDS
        • Table COLLABORATIONS OF UNIVERSITIES AND RESEARCH LABS WITH SUPPLIERS IS A MAJOR TREND OBSERVED IN THIS MARKET
  • BIOSIMULATION MARKET, BY PRODUCT
    • INTRODUCTION
      • Table BIOSIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
    • SOFTWARE
      • Table BIOSIMULATION SOFTWARE MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table BIOSIMULATION SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • PK/PD MODELING AND SIMULATION SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR PK/PD MODELING AND SIMULATION SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
      • MOLECULAR MODELING AND SIMULATION SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR MOLECULAR MODELING AND SIMULATION SOFTWARE, BY REGION, 2013-2020 (USD MILLION
      • PBPK MODELING AND SIMULATION SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR PBPK MODELING AND SIMULATION SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
      • TOXICITY PREDICTION SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR TOXICITY PREDICTION SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
      • TRIAL DESIGN SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR TRIAL DESIGN SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
      • OTHER SOFTWARE
        • Table BIOSIMULATION MARKET SIZE FOR OTHER SOFTWARE, BY REGION, 2013-2020 (USD MILLION)
    • SERVICES
      • Table BIOSIMULATION SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table BIOSIMULATION SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
      • IN-HOUSE SERVICES
        • Table BIOSIMULATION MARKET SIZE FOR IN-HOUSE SERVICES, BY REGION, 2013-2020 (USD MILLION)
      • EXTERNAL/CONTRACT SERVICES
        • Table BIOSIMULATION MARKET SIZE FOR EXTERNAL/CONTRACT SERVICES, BY REGION, 2013-2020 (USD MILLION)
  • BIOSIMULATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table BIOSIMULATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • DRUG DEVELOPMENT
      • Table BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT, BY APPLICATION, 2013-2020 (USD MILLION )
      • Table BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT, BY REGION, 2013-2020 (USD MILLION)
      • PRECLINICAL TESTING
        • Table BIOSIMULATION MARKET SIZE FOR PRECLINICAL TESTING, BY APPLICATION, 2013-2020 (USD MILLION )
        • Table BIOSIMULATION MARKET SIZE FOR PRECLINICAL TESTING, BY REGION, 2013-2020 (USD MILLION )
        • Table BIOSIMULATION MARKET SIZE FOR PK/PD, BY REGION, 2013-2020 (USD MILLION)
        • Table BIOSIMULATION MARKET SIZE FOR ADME/TOX, BY REGION, 2013-2020 (USD MILLION)
      • CLINICAL TRIALS
        • Table BIOSIMULATION MARKET SIZE FOR CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION)
    • DRUG DISCOVERY
      • Table BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY, BY APPLICATION, 2013-2020 (USD MILLION )
      • Table BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2013-2020 (USD MILLION )
      • TARGET IDENTIFICATION AND VALIDATION
        • Table BIOSIMULATION MARKET SIZE FOR TARGET IDENTIFICATION AND OPTIMIZATION, BY REGION, 2013-2020 (USD MILLION)
      • LEAD IDENTIFICATION AND OPTIMIZATION
        • Table BIOSIMULATION MARKET SIZE FOR LEAD IDENTIFICATION AND OPTIMIZATION, BY REGION, 2013-2020 (USD MILLION)
    • OTHER APPLICATIONS
      • Table BIOSIMULATION MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 (USD MILLION )
  • BIOSIMULATION MARKET, BY END USER
    • INTRODUCTION
      • Table BIOSIMULATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
      • Table BIOSIMULATION MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION)
    • ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
      • Table BIOSIMULATION MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table BIOSIMULATION MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION)
    • REGULATORY AUTHORITIES
      • Table BIOSIMULATION MARKET SIZE FOR REGULATORY AUTHORITIES, BY REGION, 2013-2020 (USD MILLION)
    • OTHER END USERS
      • Table BIOSIMULATION MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • GLOBAL BIOSIMULATION MARKET, BY REGION
    • INTRODUCTION
      • Table BIOSIMULATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMULATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • EUROPE
      • Table EUROPE: BIOSIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table EUROPE: BIOSIMULATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • ASIA
      • Table ASIA: BIOSIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ASIA: BIOSIMULATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: BIOSIMULATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE, BY SERVICE, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE FOR DRUG DEVELOPMENT APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROW: BIOSIMULATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • STRATEGIC OVERVIEW
    • LEADING PLAYERS IN THE BIOSIMULATION MARKET
      • Table RANK OF COMPANIES IN THE GLOBAL BIOSIMULATION MARKET, 2015
    • COMPETITIVE SITUATION AND TRENDS
      • Table MARKET DEVELOPMENTS BETWEEN 2013-2015
      • PRODUCT UPGRADATION
        • Table PRODUCT UPGRADATION, 2013-2015
      • AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS, 2013-2015
      • NEW PRODUCT AND SERVICE LAUNCHES
        • Table NEW PRODUCT AND SERVICE LAUNCHES, 2013-2015
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2015
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2013-2015
  • COMPANY PROFILES
    • INTRODUCTION
    • CERTARA USA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SIMULATION PLUS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DASSAULT SYSTÈMES SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SCHRÖDINGER INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ADVANCED CHEMISTRY DEVELOPMENT, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • CHEMICAL COMPUTING GROUP, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ENTELOS HOLDING CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GENEDATA AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • PHYSIOMICS PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • RHENOVIA PHARMA LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report